News The CHMP Adopts Positive Opinion on Amgen’s Tepezza to Treat Thyroid Eye Disease ByDipanshu DixitApril 25, 20250Comments
News Purpose Pharma’s Attrogy Receives the CHMP’s Positive Opinion for the Treatment of Hereditary Transthyretin-mediated Amyloidosis ByDipanshu DixitApril 25, 20250Comments
News Orion Pharma Collaborates with Criceto for Aporon to Treat OFF Episodes in Parkinson’s DiseaseByRidhi RastogiApril 25, 20250Comments
News CIRCA Scientific Reports the US FDA’s 510(k) Clearance of PeriCross Epicardial Access Kit for Controlled Pericardial Space AccessByRidhi RastogiApril 25, 20250Comments
News Johnson & Johnson’s Tremfya Receives the EC’s Approval for Active Ulcerative Colitis (UC)ByRidhi RastogiApril 25, 20250Comments
News VivaVision Biotech Reports Topline P-II Trial Data of VVN461 for Non-Infectious Anterior UveitisByRidhi RastogiApril 25, 20250Comments
News AbbVie Reports the US FDA’s BLA Submission for TrenibotulinumtoxinE (TrenibotE) to Treat Glabellar LinesByRidhi RastogiApril 25, 20250Comments
News PTC Therapeutics’ Sephience Receives the CHMP’s Positive Opinion for the Treatment of Phenylketonuria (PKU) ByDipanshu DixitApril 25, 20250Comments
News Gedeon Richter Receives CHMP’s Positive Opinion for Junod and Yaxwer (Biosimilars, Prolia and Xgeva) ByDipanshu DixitApril 25, 20250Comments
